October 2011 - Page 8 of 25

FridayOct 21, 2011 1:49 pm

New Drug from Sunshine Biopharma, Inc. (SBFM) to Play Critical Role in Fight against Cancer

It’s easy to forget that, in spite of periodic frustrations and disappointments, very real progress has been and continues to be made in the war against cancer. Decades of research have given us a much better understanding of how cancer operates at the cellular level. Developments in cancer prevention, screening, and therapy have saved millions of lives. Although there are still 1.5 million new cases of cancer diagnosed in the U.S. every year, the country now also has at least 11 million survivors of various types of cancer. But it’s important to remember that virtually all types of cancer are…

FridayOct 21, 2011 1:19 pm

Beacon Equity Research: Q3 Revenue and Reverse Acquisition Drives Clean Diesel Technologies (CDTI)

Clean Diesel Technologies, Inc. surged 21.35% higher during this morning’s trading session and has traded as high as $3.65 on the back of Q3 preliminary results. CDTI is a cleantech emissions reduction company that has also recently entered into an equity purchase agreement with the investing firm Lincoln Park Capital Fund. CDTI refers to the Catalytic Solutions, Inc. acquisition as the “Merger” and accounts for the reverse acquisition. Accordingly, Clean Diesel’s (the legal acquirer’s) consolidated financial statements are now those of CSI (the accounting acquirer), with the assets and liabilities and revenues and expenses of legacy Clean Diesel being included…

FridayOct 21, 2011 10:02 am

Hanwha SolarOne, Ltd. (HSOL) Video Chart for Friday, October 21, 2011

A base has been formed and indicators are turning upward. Plus, the last two candles have formed a bullish engulfing pattern. Traders will be looking for confirmation of the pattern. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayOct 21, 2011 9:52 am

OncoSec Medical Inc. (ONCS) Submits Device Master File to FDA for Medical System that Treats Solid Tumor Cancers

OncoSec Medical Inc., an advanced-stage biomedical company focused on commercializing therapeutic oncology products, today announced that they have submitted to the US Food and Drug administration (FDA) the Device Master File (DMF) for their patented Onco Medical System (OMS). The OncoSec Medical System has been shown to be safe and effective for the treatment of solid tumor cancer cells in numerous clinical trials. The regulatory filling of the DMF, which includes technical manufacturing, clinical and non-clinical information, allows the FDA to review the complete OncoSec Medical system when any investigational clinical study application references its use. "This DMF submission brings…

ThursdayOct 20, 2011 2:32 pm

Tranzyme Pharma (TZYM) Listed on Deloitte’s 2011 Technology Fast 500

Located in North Carolina, Tranzyme is a late-stage biopharmaceutical company focused on discovering, developing and commercializing novel, mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders. Today, Tranzyme took a major step towards prominence with the announcement they have been ranked as the 54th fastest growing company in North American on Deloitte’s 2011 Technology Fast 500. Leading the way at Tranzyme Pharma is Vipin Garg whom serves as the company’s President and CEO. In reference to this honor, Garg was quoted as saying, "We are very pleased to be recognized by Deloitte as one of the fastest growing…

ThursdayOct 20, 2011 12:57 pm

TiVUS, Inc. (TIVU) Provides Comprehensive Investor Update

Earlier today, TiVUS, Inc. reported on ongoing sales and installations initiatives, as well as the company's regulatory compliance activities. "I would like to update TiVUS friends and shareholders on a number of new and ongoing projects of interest to all," commented Shiva Prakash, TiVUS' president and chief executive officer. "Foremost, I would like to relay that we are awaiting the return of an executed five-year, multi-million dollar contract from Host Hotels & Resorts ("Host") for the fully operational high-definition ("HD") internet-protocol television ("IPTV") platform with TiVUS' proprietary ad-insertion system,” he continued. “The inaugural installation is currently running in Host's premier…

ThursdayOct 20, 2011 12:50 pm

Stevia Corp. (STEV) Appoints New Chief Scientist to Head Vietnam-based Stevia Developments

Stevia Corp., a farm management company focused on the economic development of alternative sweetner, Stevia, today announced Dr. Young Cheol Cho as the company’s new chief scientist. He will be based in Vietnam with the responsibility of spearheading the development of Stevia. "Through our development agreement with Agro Genesis we are extremely fortunate that they have provided us with the expert services of Dr. Cho on a dedicated full time basis. He will be living in Vietnam where he will assemble a team of experts to lead and accelerate our field program targeting the yield and quality of our Stevia…

ThursdayOct 20, 2011 12:45 pm

Beacon Equity Research: TranS1 (TSON) Shares Drop more than 40% on Subpoena from Government

Shares of TranS1 Inc., a medical device company engaged in the designing, development and marketing of products that implement its minimally invasive surgical approach to treat degenerative disc disease, are down more than 40% this week. The huge sell-off in TranS1 shares was sparked after the company announced on Monday that it received a subpoena from the U.S. Department of Health and Human Services (HHS). In a regulatory filing, TranS1 said that HHS is seeking documents from January 1, 2011, through October 6, 2011. Although TranS1 claims that HHS has made no claims against it, the news triggered a huge…

ThursdayOct 20, 2011 12:40 pm

Beacon Equity Research: Amylin Pharmaceuticals (AMLN) Shares Rally on Wider Approval for Diabetes Drug

Shares of Amylin Pharmaceuticals Inc., a biopharmaceutical company focusing on the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases, are soaring in today’s trading after the company’s diabetes drug received wider approval. Amylin shares rose to an intra-day high of $11.80. At last check, the stock was trading 8.20% higher at $11.08, with volume up from daily average of 1.43 million to 2.68 million. On Wednesday Amylin said that the U.S. FDA approved wider use of Byetta in combination with Sanofi Aventis’ Lantus. Byetta is the company’s drug for type 2 diabetes.…

ThursdayOct 20, 2011 12:36 pm

Small Cap Voice: Tootie Pie (TOOT) Every Day with Rachael Ray

Tootie Pie Company, Inc. announced that it is featured in the November issue of “Every Day with Rachel Ray,” now on newsstands. The article, entitled “Pies Worth the Postage” named Tootie’s Pumpkin Pie as “The Best Pumpkin Pie.” “We are delighted that the folks at ‘Every Day’ chose Tootie Pumpkin Pie as the best,” said Don Merrill, President & CEO. “Rachael Ray is a nationally recognized personality whose name is synonymous with great food and quality. We welcome her readers to try some of our other wonderful pies as well.” “Whether it’s the Food Network, Neiman Marcus or Southern Living,…

Site Search

Company Search

Month: October 2011